NON-FINAL ACTION - MAILED
final action
on 22 Nov 2024
Last Applicant/ Owned by
01307 Dresden
XP
Serial Number
79408326 filed on 14th Dec 2023
Registration Number
N/A
Correspondent Address
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
SEAMLESS
Scientific and technological services and research, especially creation and application of bioinformatic algorithms and models; science and technology services, scientific and technological research, scientific development services, technological development, relating to the following sectors: gene, genome and cell editing, modulation, modification, engineering, regulation, repair and therapy for Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Medical services; medical analysis relating to the treatment of persons; assay services, for treatment purposes; medical services and medical services, in relation to the following fields: genome editing; genetic counseling; therapy services; services for the preparation of medical reports; providing personalised healthcare and medical information; providing therapy recommendations; providing of information and counselling services, in relation to the following fields: medical services, health care services; therapy consultancy, in relation to the following fields: genome editing; counselling relating to recombinases and integrases for the treatment of diseases.
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
Scientific and technological services and research, especially creation and application of bioinformatic algorithms and models; science and technology services, scientific and technological research, scientific development services, technological development, relating to the following sectors: gene, genome and cell editing, modulation, modification, engineering, regulation, repair and therapy for the development of pharmaceutical and biological preparations or medications for humans and diagnostic goods and services; consultancy services relating to development of pharmaceutical and biological preparations or medications for humans in the field of gene, genome and cell editing, modulation, modification, engineering, regulation, repair and therapy; genome engineering services; scientific research relating to genetics, scientific research, relating to the following sectors: genome editing; analytical laboratory services; medical laboratory services; scientific laboratory services; research laboratories; scientific research and development; development of pharmaceutical preparations and medicines; pharmaceutical products development; bioinformatic research for identification of target sequences for genome editing in a cell's DNA; bioinformatic research for identification of target sequences for genome editing in a cell's DNA by genome editable enzymes, DNA recombinant enzymes, DNA editable enzymes, in particular recombinases and integrases; bioinformatic or computational analysis to identify target sequences in a cell's DNA; screening processes for the identification of genome editable enzymes, DNA recombinant enzymes, DNA editable enzymes, in particular recombinases and integrases; research and development for the pharmaceutical industry; technological consultancy, relating to the following sectors: treatment of diseases by means of genome editable enzymes, DNA recombinant enzymes, DNA editable enzymes, in particular recombinases and integrases.
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [010]
Medical Instrument Products
Medical apparatus and instruments; laboratory apparatus for medical diagnostic purposes.
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceutical and biological preparations or active substances for the treatment of diseases; medical, pharmaceutical and biopharmaceutical preparations and substances for the treatment of diseases; pharmaceutical goods and preparations, namely gene transfer, regulation, modulation and delivery medications for the treatment of genetic diseases and disorders; products, agents, for medical purposes, for veterinary purposes; genome editable enzymes; DNA recombinant enzymes; DNA editable enzymes, especially, recombinases and integrases; genome editable enzymes for the treatment of diseases; DNA recombinant enzymes for the treatment of diseases; DNA editable enzymes, in particular recombinases and integrases, for the treatment of diseases.
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Chemicals for use in industry and science; biological preparations, biological reagents, for use in industry and science.
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79408326
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Design Code(s)
26.17.09 -
Curved line(s), band(s) or bar(s)
Legal History
| Status Date | Action Taken |
|---|---|
| 14th Dec 2024 | REFUSAL PROCESSED BY IB |
| 22nd Nov 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| 22nd Nov 2024 | REFUSAL PROCESSED BY MPU |
| 15th Nov 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| 14th Nov 2024 | NON-FINAL ACTION WRITTEN |
| 05th Nov 2024 | ASSIGNED TO EXAMINER |
| 04th Nov 2024 | APPLICATION FILING RECEIPT MAILED |
| 04th Nov 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 31st Oct 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |